Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing

被引:12
|
作者
Pujol, Nina [1 ]
Heeke, Simon [2 ]
Bontoux, Christophe [3 ,4 ]
Boutros, Jacques [4 ,5 ]
Ilie, Marius [3 ,4 ]
Hofman, Veronique [3 ,4 ]
Marquette, Charles-Hugo [4 ,5 ]
Hofman, Paul [3 ,4 ]
Benzaquen, Jonathan [4 ,5 ]
机构
[1] Cote dAzur Univ, Ctr Antoine Lacassagne, Dept Radiat Oncol, F-06000 Nice, France
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[3] Cote dAzur Univ, Ctr Hosp Univ Nice, Lab Clin & Expt Pathol, Pasteur Hosp 1,FHU OncoAge, Biobank BB 0033 00025, F-06000 Nice, France
[4] Cote dAzur Univ, Inst Res Canc & Aging, INSERM U1081, CNRS,UMR 7284, F-06000 Nice, France
[5] Cote dAzur Univ, Ctr Hosp Univ Nice, Dept Pulm Med & Thorac Oncol, FHU OncoAge,Pasteur Hosp 1, F-06000 Nice, France
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 10期
关键词
next-generation sequencing; predictive biomarker; non-small cell lung carcinoma; precision oncology; OPEN-LABEL; TARGETED THERAPY; CANCER PATIENTS; SOLID TUMORS; FUSION; MUTATION; IMMUNOHISTOCHEMISTRY; GENE; CHEMOTHERAPY; DRIVER;
D O I
10.3390/jpm12101684
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Molecular diagnosis of lung cancer is a constantly evolving field thanks to major advances in precision oncology. The wide range of actionable molecular alterations in non-squamous non-small cell lung carcinoma (NS-NSCLC) and the multiplicity of mechanisms of resistance to treatment resulted in the need for repeated testing to establish an accurate molecular diagnosis, as well as to track disease evolution over time. While assessing the increasing complexity of the molecular composition of tumors at baseline, as well as over time, has become increasingly challenging, the emergence and implementation of next-generation sequencing (NGS) testing has extensively facilitated molecular profiling in NS-NSCLC. In this review, we discuss recent developments in the molecular profiling of NS-NSCLC and how NGS addresses current needs, as well as how it can be implemented to address future challenges in the management of NS-NSCLC.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Reflex testing in non-small cell lung carcinoma using DNA-and RNA-based next-generation sequencing-a single-center experience
    Zacharias, Martin
    Absenger, Gudrun
    Kashofer, Karl
    Wurne, Robert
    Lindenmann, Joerg
    Terbuch, Angelika
    Konjic, Selma
    Sauer, Stefan
    Gollowitsch, Franz
    Gorkiewicz, Gregor
    Brcic, Luka
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4221 - +
  • [32] Next Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Testing Yields More Actionable Results
    Mehrad, Mitra
    Nikiforova, Marina
    Bittar, Humberto Trejo
    Dacic, Sanja
    LABORATORY INVESTIGATION, 2016, 96 : 476A - 477A
  • [33] Next Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Testing Yields More Actionable Results
    Mehrad, Mitra
    Nikiforova, Marina
    Billet, Humberto Trejo
    Deck, Sanja
    MODERN PATHOLOGY, 2016, 29 : 476A - 477A
  • [34] Relevance of Next-Generation Sequencing in Non-Small Cell Lung Cancer; Molecular Epidemiology Study in Indian Patients
    Aggarwal, Aditi
    Sabnis, Neha
    Mishra, Avshesh
    Kumar, Vipin
    Mohanty, Sagar Samrat
    Kini, Lata
    Sharma, Shivani
    Mohanty, Sambit
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1087 - 1088
  • [35] The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    Wang, Qiming
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2948 - +
  • [36] Relevance of Next-Generation Sequencing in Non-Small Cell Lung Cancer; Molecular Epidemiology Study in Indian Patients
    Aggarwal, Aditi
    Sabnis, Neha
    Mishra, Avshesh
    Kumar, Vipin
    Mohanty, Sagar Samrat
    Kini, Lata
    Sharma, Shivani
    Mohanty, Sambit
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1087 - 1088
  • [37] The correlation between Crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Song, Yong
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Genetic Profiling of Idiopathic Pulmonary Fibrosis Associated Non-Small Cell Lung Cancer by Targeted Next-Generation Sequencing
    Otsubo, K.
    Iwama, E.
    Tanaka, K.
    Shiraishi, Y.
    Yoneshima, Y.
    Inoue, H.
    Tagawa, T.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S953 - S953
  • [39] Comparing molecular diagnostic using In-house reflex testing and Next-Generation Sequencing (NGS), A cancer alliance experience in Non-small cell lung cancer (NSCLC)
    Hassan, Heba
    Donald, Gillian
    Shah, Riyaz
    LUNG CANCER, 2024, 190
  • [40] SUCCESS OF NEXT GENERATION SEQUENCING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER USING ENDOBRONCHIAL ULTRASOUND GUIDED FINE NEEDLE ASPIRATION SAMPLES
    Zhang, Chenchen
    Kim, Roger
    Andronov, Michelle
    Ma, Kevin
    Hutchinson, Christoph
    Moon, Edmund
    Thompson, Jeffrey
    McGrath, Cindy
    DiBardino, David
    CHEST, 2021, 160 (04) : 1618A - 1619A